Acadia Healthcare Statistics
Acadia Healthcare (7RA) Stock Statistics & Valuation Metrics
Total Valuation
Acadia Healthcare has a market cap or net worth of EUR 3.19B. The enterprise value is EUR 5.09B.
- Market Cap
- EUR 3.19B
- Enterprise Value
- EUR 5.09B
Share Statistics
Acadia Healthcare has 92,966,680 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 92,966,680
- Owned by Insiders
- 2.12%
- Owned by Institutions
- 88.65%
Financial Efficiency
Acadia Healthcare’s return on equity (ROE) is -0.57 and return on invested capital (ROIC) is 7.68%.
- Return on Equity (ROE)
- -0.57
- Return on Assets (ROA)
- -0.20
- Return on Invested Capital (ROIC)
- 7.68%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 150.58K
- Profits Per Employee
- -50.13K
- Employee Count
- 22,000
- Asset Turnover
- 0.60
- Inventory Turnover
- 480.01
Valuation Ratios
The current PE Ratio of Acadia Healthcare is -3.03. Acadia Healthcare’s PEG ratio is 0.00.
- PE Ratio
- -3.03
- PS Ratio
- 1.03
- PB Ratio
- 1.70
- Price to FCF
- -147.19
- Price to Operating Cash Flow
- 14.60
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Acadia Healthcare had revenue of 3.31B and earned -1.10B in profits. Earnings per share was -12.16.
- Revenue
- 3.31B
- Gross Profit
- 583.44M
- Operating Income
- 387.96M
- Pretax Income
- -1.07B
- Net Income
- -1.10B
- EBITDA
- -737.83M
- Earnings Per Share (EPS)
- -12.16
Cash Flow
In the last 12 months, operating cash flow was 235.19M and capital expenditures -259.05M, giving a free cash flow of -23.86M billion.
- Operating Cash Flow
- 235.19M
- Free Cash Flow
- -23.86M
- Free Cash Flow per Share
- -0.26
Dividends & Yields
Acadia Healthcare pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -0.68%
- Earnings Yield
- -32.85%
Stock Price Statistics
- Beta
- 0.04
- 52-Week Price Change
- 131.08%
- 50-Day Moving Average
- 27.00
- 200-Day Moving Average
- 23.31
- Relative Strength Index (RSI)
- 75.03
- Average Volume (3m)
- 94
Important Dates
Acadia Healthcare upcoming earnings date is Mar 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Mar 01, 2027
- Ex-Dividend Date
- ―
Financial Position
Acadia Healthcare as a current ratio of 1.55, with Debt / Equity ratio of 136.22%
- Current Ratio
- 1.55
- Quick Ratio
- 1.54
- Debt to Market Cap
- 1.96
- Net Debt to EBITDA
- -3.42
- Interest Coverage Ratio
- 2.79
Taxes
In the past 12 months, Acadia Healthcare has paid 25.98M in taxes.
- Income Tax
- 25.98M
- Effective Tax Rate
- -0.02
Enterprise Valuation
Acadia Healthcare EV to EBITDA ratio is -8.86, with an EV/FCF ratio of -245.27.
- EV to Sales
- 1.72
- EV to EBITDA
- -8.86
- EV to Free Cash Flow
- -245.27
- EV to Operating Cash Flow
- 24.88
Balance Sheet
Acadia Healthcare has EUR 163.31M in cash and marketable securities with EUR 2.50B in debt, giving a net cash position of -EUR 2.34B billion.
- Cash & Marketable Securities
- EUR 163.31M
- Total Debt
- EUR 2.50B
- Net Cash
- -EUR 2.34B
- Net Cash Per Share
- -EUR 25.17
- Tangible Book Value Per Share
- EUR 9.20
Margins
Gross margin is 16.10%, with operating margin of 9.77%, and net profit margin of -33.07%.
- Gross Margin
- 16.10%
- Operating Margin
- 9.77%
- Pretax Margin
- -31.66%
- Net Profit Margin
- -33.07%
- EBITDA Margin
- -19.37%
- EBIT Margin
- -25.28%
Analyst Forecast
The average price target for Acadia Healthcare is EUR 35.46, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 35.46
- Price Target Upside
- 3.69% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 12
- Revenue Growth Forecast
- -0.56%
- EPS Growth Forecast
- -1113.32%
Scores
- Smart Score
- 7
- AI Score
- ―

